Literature DB >> 26165392

Vitamin B₂ Sensitizes Cancer Cells to Vitamin-C-Induced Cell Death via Modulation of Akt and Bad Phosphorylation.

Ni Chen1, Shutao Yin1, Xinhua Song1, Lihong Fan2, Hongbo Hu1.   

Abstract

Vitamin C is an essential dietary nutrient that has a variety of biological functions. Recent studies have provided promising evidence for its additional health benefits, including anticancer activity. Vitamin B2, another essential dietary nutrient, often coexists with vitamin C in some fruits, vegetables, or dietary supplements. The objective of the present study is to determine whether the combination of vitamin C and B2 can achieve a synergistic anticancer activity. MDA-MB-231, MCF-7, and A549 cells were employed to evaluate the combinatory effects of vitamin C and B2. We found that the combination of vitamin C and B2 resulted in a synergistic cell death induction in all cell lines tested. Further mechanistic investigations revealed that vitamin B2 sensitized cancer cells to vitamin C through inhibition of Akt and Bad phosphorylation. Our findings identified vitamin B2 as a promising sensitizer for improving the efficacy of vitamin-C-based cancer chemoprevention and chemotherapy.

Entities:  

Keywords:  Akt; Bad; cell death; vitamin B2; vitamin C

Mesh:

Substances:

Year:  2015        PMID: 26165392     DOI: 10.1021/acs.jafc.5b01909

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  4 in total

1.  Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells.

Authors:  Edna Ooko; Onat Kadioglu; Henry J Greten; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-02-02       Impact factor: 5.810

2.  The effect of "NutramilTM Complex," food for special medical purpose, on breast and prostate carcinoma cells.

Authors:  Aneta A Koronowicz; Mariola Drozdowska; Barbara Wielgos; Ewelina Piasna-Słupecka; Dominik Domagała; Joanna Dulińska-Litewka; Teresa Leszczyńska
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

3.  Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia.

Authors:  Aparna Natarajan; Rajkumar Thangarajan; Sabitha Kesavan
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01

4.  Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines.

Authors:  Eva Kiss; Gertrud Forika; Reka Mohacsi; Zsuzsanna Nemeth; Tibor Krenacs; Magdolna Dank
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.